<DOC>
	<DOCNO>NCT02490748</DOCNO>
	<brief_summary>The purpose study determine whether combine radiofrequency ablation ( RFA ) cytokine-induced killer cell ( CIK ) transfusion prolong survival patient cervical cancer .</brief_summary>
	<brief_title>Radiofrquency Ablation Combined With Cytokine-induced Killer Cells Patients With Cervical Cancer</brief_title>
	<detailed_description>The primary objective evaluate whether RFA follow CIK transfusion prolong survival patient cervical cancer .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>They systematic review base randomize control trial ( rcts ) . They phase II rcts compare chemotherapy systemic therapy agent treatment recurrent , metastatic , persistent cervical cancer . report least one outcome : complete partial response rate , overall progressionfree survival rate , adverse effect , healthrelated quality life ( rcts report heterogeneous populations—for example , woman range disease stages—were include result give separately patient recurrent , metastatic , persistent cervical cancer ) . study evaluate role radiotherapy administer chemotherapy , second subsequentline therapy option .</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>